Otolaryngology · Setauket, NY
NPI
1700867546
Since 2005
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
19 Crane Neck Rd
Setauket, NY, 11733
Phone (516) 729-1661
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
2,045 services
Medicare patients, 2024
855
Average age 75
Drug cost, 2024
$200K
1,244 prescriptions
Company payments, 2025
$1,204
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lauren S Zaretsky was code 99213 (office e&m - established), 657 times for 474 patients. In total Lauren S Zaretsky billed 2,045 services in 27 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 657 | 474 | $80.62 | $53K |
| 69210 Other Organ Systems | Office | 285 | 239 | $41.12 | $12K |
| 31231 Nasal/Sinus Endoscopy | Office | 245 | 177 | $171.99 | $42K |
| 99203 Office E&M - New | Office | 193 | 193 | $98.74 | $19K |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 162 | 160 | $47.12 | $7,634 |
| 99214 Office E&M - Established | Office | 138 | 124 | $122.56 | $17K |
| 31575 Other Organ Systems | Office | 126 | 112 | $123.29 | $16K |
| 99204 Office E&M - New | Office | 79 | 79 | $157.22 | $12K |
| 99212 Office E&M - Established | Office | 69 | 65 | $54.79 | $3,781 |
| 99202 Office E&M - New | Office | 27 | 27 | $61.25 | $1,654 |
| 92511 Treatment - Miscellaneous | Office | 21 | 20 | $109.69 | $2,304 |
By year: 2022 $160K for 1,573 services; 2023 $211K for 2,021 services; 2024 $191K for 2,045 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lauren S Zaretsky prescribed most often to Medicare patients was Ipratropium Bromide, with 238 prescriptions and refills. In total Lauren S Zaretsky wrote 1,244 Medicare prescriptions that cost $200K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 238 | 346 | 112 | $5,581 |
| Fluticasone Propionate Generic | 159 | 221 | 83 | $2,246 |
| Azelastine Hcl Generic | 144 | 186 | 62 | $3,246 |
| Levocetirizine Dihydrochloride Generic | 78 | 230 | 32 | $946 |
| Mupirocin Generic | 61 | 61 | 55 | $376 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 59 | 59 | 54 | $373 |
| Hydrocortisone-Acetic Acid Hydrocortisone/Acetic Acid | 56 | 57 | 29 | $4,292 |
| Famotidine Generic | 46 | 127 | 26 | $614 |
| Dupixent Pen Dupilumab | 38 | 44 | Under 11 | $168K |
| Prednisone Generic | 34 | 34 | 33 | $122 |
| Nystatin Generic | 31 | 31 | 13 | $684 |
| Doxycycline Hyclate Generic | 31 | 31 | 27 | $173 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 30 | 30 | 23 | $2,778 |
| Mometasone Furoate Generic | 30 | 30 | 26 | $287 |
| Fluocinolone Acetonide Oil Generic | 28 | 31 | 17 | $1,065 |
Brand drugs: 67 claims; generic drugs: 1,177 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lauren S Zaretsky $1,204 ($1,204 in general payments such as food, travel and fees) from 15 companies. The largest payer was GlaxoSmithKline, LLC. with $276.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 12 | $276 |
| Inspire Medical Systems, Inc. INSP | 3 | $177 |
| Optinose US, Inc. | 7 | $153 |
| Spirair, Inc. | 1 | $149 |
| Stryker Corporation SYK | 5 | $135 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $96.58 |
| Paratek Pharmaceuticals, Inc. | 2 | $36.23 |
| Integra LifeSciences Corporation IART | 1 | $28.51 |
| Grifols USA, LLC | 1 | $28.48 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.